May 19, 2020 / 12:07 PM / 14 days ago

BRIEF-Be The Match Biotherapies, Nantkwest Collaborate To Develop Covid-19 treatment

May 19 (Reuters) - NantKwest Inc:

* BE THE MATCH BIOTHERAPIES AND NANTKWEST ANNOUNCE COLLABORATION TO ACCELERATE DEVELOPMENT OF CELL THERAPY TO PREVENT COVID-19 DEATHS

* BE THE MATCH BIOTHERAPIES-TO PROVIDE ALLOGENEIC CELLULAR SOURCE MATERIAL TO NANTKWEST FOR CLINICAL TRIAL ADDRESSING PRIMARY CAUSE OF COVID-19 FATALITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below